Free tool
Stocks listed on Nasdaq GS
We cover 13 companies listed on Nasdaq GS. The median market value in the group is $1.56B. Across the group, the median move over the past trading day is −0.13%. Price change over the past year runs from +3.2% to +163.8% across the middle 80 percent of the group, with a median of +45.9%.
Other lists in this group
Table
13 of 1,279 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| HQY | HealthEquity, Inc. | $8.75B | Mid cap | +18.69% | Aug 27, 2026 |
| MMED | MiniMed Group, Inc. | $5.48B | Mid cap | +5.41% | Sep 1, 2026 |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +103.83% | Oct 8, 2026 |
| NBTX | Nanobiotix S.A. | $2.26B | Mid cap | +394.99% | Sep 29, 2026 |
| MESO | Mesoblast Limited | $2.23B | Mid cap | +4.47% | Aug 27, 2026 |
| HCSG | Healthcare Services Group, Inc. | $1.57B | Small cap | +47.05% | Oct 21, 2026 |
| KMTS | Kestra Medical Technologies, Ltd. | $1.56B | Small cap | +47.61% | Sep 14, 2026 |
| INNV | InnovAge Holding Corp. | $1.48B | Small cap | +178.79% | Sep 8, 2026 |
| ANGO | AngioDynamics, Inc. | $648.51M | Small cap | +56.74% | Oct 1, 2026 |
| TLRY | Tilray Brands, Inc. | $638.38M | Small cap | −66.13% | Oct 8, 2026 |
| NRC | NRC Health | $487.06M | Small cap | +45.92% | Oct 26, 2026 |
| IPHA | Innate Pharma S.A. | $253.56M | Small cap | +2.86% | Sep 17, 2026 |
| UTMD | Utah Medical Products, Inc. | $225.70M | Small cap | +17.76% | Oct 22, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.